(Q45189727)

English

Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer's disease and healthy controls

scientific article published on 6 May 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer's disease and healthy controls (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Alzheimer's disease

0 references

florbetaben f-18

1 reference

ChEBI release 2020-05-28

author name string

Henryk Barthel

1

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Julia Luthardt

2

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Georg Becker

3

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Marianne Patt

4

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Eva Hammerstein

5

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Kristin Hartwig

6

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Birk Eggers

7

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Bernhard Sattler

8

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Andreas Schildan

9

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Swen Hesse

10

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Philipp M Meyer

11

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Henrike Wolf

12

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Torsten Zimmermann

13

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Joachim Reischl

14

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Beate Rohde

15

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Hermann-Josef Gertz

16

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Cornelia Reininger

17

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Osama Sabri

18

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

6 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

number of pages

13

1 reference

based on heuristic

inferred from page(s)

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

38

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

1702-1714

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

https://scigraph.springernature.com/pub.10.1007/s00259-011-1821-1

0 references

gamma-secretases: from cell biology to therapeutic strategies

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

Adult neurogenesis, neural stem cells and Alzheimer's disease: developments, limitations, problems and promises

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

Neuropathological stageing of Alzheimer-related changes

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

Can we do better in developing new drugs for Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

The validity of 3 clinical diagnostic criteria for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

Clinicopathological analysis of dementia disorders in the elderly.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

The Clinical Dementia Rating (CDR): current version and scoring rules

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

Screening for Alzheimer's disease by clock drawing.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

Reduced alpha4beta2*-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

[(11)C]PIB-amyloid binding and levels of Abeta40 and Abeta42 in postmortem brain tissue from Alzheimer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

Monitoring the amyloid beta-peptide in vivo--caveat emptor

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

Radiation dosimetry of beta-amyloid tracers 11C-PiB and 18F-BAY94-9172.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

The role of apolipoprotein E in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

Imaging beta-amyloid burden in aging and dementia.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

Frequent amyloid deposition without significant cognitive impairment among the elderly

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

An evaluation of dementia screening in the primary care setting

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1821-1

21 January 2018

Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21547601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cognition, glucose metabolism and amyloid burden in Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21547601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-¹¹C]-2-(4'-methylaminophenyl)- 6-hydroxybenzothiazole.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21547601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21547601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Memory profiling in mild cognitive impairment: can we determine risk for Alzheimer's disease?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21547601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic targets for Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21547601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21547601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00259-011-1821-1

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45189727&oldid=2069425253"